Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Viridian Therapeutics stock
Learn how to easily invest in Viridian Therapeutics stock.
Viridian Therapeutics Inc is a biotechnology business based in the US. Viridian Therapeutics shares (VRDN) are listed on the NASDAQ and all prices are listed in US Dollars. Viridian Therapeutics employs 26 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Viridian Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VRDN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Viridian Therapeutics stock price (NASDAQ: VRDN)Use our graph to track the performance of VRDN stocks over time.
Viridian Therapeutics shares at a glance
|Latest market close||$19.66|
|52-week range||$10.44 - $25.19|
|50-day moving average||$19.54|
|200-day moving average||$16.93|
|Wall St. target price||$35.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-19.21|
Buy Viridian Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Viridian Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Viridian Therapeutics price performance over time
|1 week (2022-01-14)||-1.70%|
|1 month (2021-12-21)||-4.10%|
|3 months (2021-10-21)||17.80%|
|6 months (2021-07-21)||16.26%|
|1 year (2021-01-21)||-2.04%|
|2 years (2020-01-21)||3,140.48%|
|3 years (2019-01-18)||550.99%|
|5 years (2017-01-20)||96.80%|
Viridian Therapeutics financials
|Revenue TTM||$2.8 million|
|Gross profit TTM||$-26,954,000|
|Return on assets TTM||-34.98%|
|Return on equity TTM||-125.17%|
|Market capitalisation||$412.9 million|
TTM: trailing 12 months
Viridian Therapeutics share dividends
We're not expecting Viridian Therapeutics to pay a dividend over the next 12 months.
Have Viridian Therapeutics's shares ever split?
Viridian Therapeutics's shares were split on a 1:15 basis on 12 November 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Viridian Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Viridian Therapeutics shares which in turn could have impacted Viridian Therapeutics's share price.
Viridian Therapeutics share price volatility
Over the last 12 months, Viridian Therapeutics's shares have ranged in value from as little as $10.44 up to $25.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viridian Therapeutics's is 1.0806. This would suggest that Viridian Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Viridian Therapeutics overview
Viridian Therapeutics, Inc. , a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibody product specifically designed for thyroid eye disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc.
Viridian Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Viridian Therapeutics is owned by insiders or institutions?
Currently 4.485% of Viridian Therapeutics shares are held by insiders and 92.797% by institutions. How many people work for Viridian Therapeutics?
Latest data suggests 26 work at Viridian Therapeutics. When does the fiscal year end for Viridian Therapeutics?
Viridian Therapeutics's fiscal year ends in December. Where is Viridian Therapeutics based?
Viridian Therapeutics's address is: 6200 Lookout Road, Boulder, CO, United States, 80301 What is Viridian Therapeutics's ISIN number?
Viridian Therapeutics's international securities identification number is: US92790C1045
More guides on Finder
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Ask an Expert